STEINMAN LAWRENCE 13D and 13G filings for Pasithea Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-06-07 6:29 pm Purchase | 2023-06-02 | 13D | Pasithea Therapeutics Corp. KTTA | STEINMAN LAWRENCE | 78,859 6.000% | 78,859 (New Position) | Filing |